Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advanced Heart Failure: The Predictive Value of Dobutamine Echo-stress in the Clinical Response to Cardiac Contractility Modulation Therapy (CCM)

NCT06973902 is registered in ClinicalTrials.gov with Quovadis Associazione as lead sponsor.

NCT NCT06973902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06973902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advanced Heart Failure: The Predictive Value of Dobutamine Echo-stress in the Clinical Response to Cardiac Contractility Modulation Therapy (CCM)
Lead sponsor
Quovadis Associazione
Phase
Observational
Overall status
Recruiting
Start date
July 10, 2025
Completion date
December 31, 2028
Enrollment
120 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic congestive heart failure